PerspectiveImmunology

The Shape of Things to Come

Science  15 Jun 2007:
Vol. 316, Issue 5831, pp. 1574-1576
DOI: 10.1126/science.1144483

You are currently viewing the summary.

View Full Text

Via your Institution

Log in through your institution

Log in through your institution


Summary

Mechanistic understanding of how ligands can fine-tune the immune response may lead to better vaccine adjuvants.